Crunching the numbers for TGTX... Refresh in a moment for the full analysis.
TG THERAPEUTICS, INC. (TGTX)
Healthcare
mixed
$33.73
Updated: 2026-04-12
57
TradeApes Score
hold
Financial Strength
50
Mixed
Operating Trend
60
Healthy
Valuation
60
Healthy
Capital Allocation
40
Weak
Risk
80
Strong
Key Findings
+
Historically cheap — EV/EBITDA in bottom 25% of its 5-year range
−
FCF deteriorating — free cash flow down more than 25% year over year
See the full analysis
Quarterly financials, DCF valuation model, Watchlist, and Stock Screener.
Create Free Account
Scores and valuations are model outputs, not investment advice. TradeApes does not provide financial, tax, or investment advice.